Evidence map›Paper›PMID 33851156›Full record

ArticlebioRxiv : the preprint server for biology2021

SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques.

Carolina Garrido, Alan D Curtis, Maria Dennis, Sachi H Pathak, Hongmei Gao, David Montefiori, Mark Tomai, Christopher B Fox, Pamela A Kozlowski, Trevor Scobey and 15 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 1 country.

Carolina Garrido
Alan D Curtis
Maria Dennis
Sachi H Pathak
Hongmei Gao
David Montefiori
Mark Tomai
Christopher B Fox
Pamela A Kozlowski
Trevor Scobey
Jennifer E Munt
Michael L Mallroy
Pooja T Saha
Michael G Hudgens
Lisa C Lindesmith
Ralph S Baric
Olubukola M Abiona
Barney Graham
Kizzmekia S Corbett
Darin Edwards
Andrea Carfi
Genevieve Fouda
Koen K A Van Rompay
Kristina De Paris
Sallie R Permar
University of North Carolina at Chapel Hill · USDuke Medical Center · USNational Institutes of Health · USModerna Therapeutics (United States) · USCornell University · USInfectious Disease Research Institute · USLouisiana State University Health Sciences Center New Orleans · USUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early life SARS-CoV-2 vaccination has the potential to provide lifelong protection and achieve herd immunity. To evaluate SARS-CoV-2 infant vaccination, we immunized two groups of 8 infant rhesus macaques (RMs) at weeks 0 and 4 with stabilized prefusion SARS-CoV-2 S-2P spike (S) protein, either encoded by mRNA encapsulated in lipid nanoparticles (mRNA-LNP) or mixed with 3M-052-SE, a TLR7/8 agonist in a squalene emulsion (Protein+3M-052-SE). Neither vaccine induced adverse effects. High magnitude S-binding IgG and neutralizing infectious dose 50 (ID ONE-SENTENCE SUMMARY: SARS-CoV-2 vaccines are well-tolerated and highly immunogenic in infant rhesus macaques.

Identifiers

PMID33851156
PMCPMC8043446
OpenAlexW3142934551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.